SAUG-1

N/A

Report date: 2025/02/18 10:49:56

Base Information

Drug NameSAUG-1
Drug Alias NameSAUG-1
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionProgrammed cell death protein 1 blockersVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factorProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSaugatuck Therapeutics LtdPortage Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesSaugatuck Therapeutics LtdPortage Biotech Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A